TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer

American Journal of Pathology

Volumn 180, Issue 2, 2012, Pages 839-847

  Liu, Jin ^a   Welm, Bryan ^a   Boucher, Ken M ^a   Ebbert, Mark T W ^b   Bernard, Philip S ^b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; TRIPARTITE MOTIF PROTEIN 29; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER RELAPSE; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84862919785     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.10.020     Document Type: Article

References (33)

1. L.N. Kapp, R.B. Painter Stable radioresistance in ataxia-telangiectasia cells containing DNA from normal human cells Int J Radiat Biol 56 1989 667 675
2. L.N. Kapp, R.B. Painter, L.C. Yu, N. van Loon, C.W. Richard 3rd, M.R. James, D.R. Cox, J.P. Murnane Cloning of a candidate gene for ataxia-telangiectasia group D Am J Hum Genet 51 1992 45 54
3. E. Boder, R.P. Sedgwick Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection Pediatrics 21 1958 526 554
4. A. Reymond, G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, A. Guffanti, S. Minucci, P.G. Pelicci, A. Ballabio The tripartite motif family identifies cell compartments EMBO J 20 2001 2140 2151
5. T. Sjoblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S.D. Markowitz, J. Willis, D. Dawson, J.K. Willson, A.F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B.H. Park, K.E. Bachman, N. Papadopoulos, B. Vogelstein, K.W. Kinzler, V.E. Velculescu The consensus coding sequences of human breast and colorectal cancers Science 314 2006 268 274
6. Y. Hosoi, L.N. Kapp, J.P. Murnane, Y. Matsumoto, A. Enomoto, T. Ono, K. Miyagawa Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene ATDC Biochem Biophys Res Commun 348 2006 728 734
7. Y. Kosaka, H. Inoue, T. Ohmachi, T. Yokoe, T. Matsumoto, K. Mimori, F. Tanaka, M. Watanabe, M. Mori Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer Ann Surg Oncol 14 2007 2543 2549
8. L. Wang, D.G. Heidt, C.J. Lee, H. Yang, C.D. Logsdon, L. Zhang, E.R. Fearon, M. Ljungman, D.M. Simeone Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization Cancer Cell 15 2009 207 219
9. Z. Yuan, A. Villagra, L. Peng, D. Coppola, M. Glozak, E.M. Sotomayor, J. Chen, W.S. Lane, E. Seto The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions Mol Cell Biol 30 2010 3004 3015
10. P.J. Kushner, E. Hort, J. Shine, J.D. Baxter, G.L. Greene Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens Mol Endocrinol 4 1990 1465 1473
11. M.J. Pilat, J.K. Christman, S.C. Brooks Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6 Breast Cancer Res Treat 37 1996 253 266
12. J. Debnath, S.K. Muthuswamy, J.S. Brugge Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 2003 256 268
13. S.K. Muthuswamy, D. Li, S. Lelievre, M.J. Bissell, J.S. Brugge ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini Nat Cell Biol 3 2001 785 792
14. Y.H. Yang, S. Dudoit, P. Luu, D.M. Lin, V. Peng, J. Ngai, T.P. Speed Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res 30 2002 e15
15. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, S.H. Friend Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
16. Y. Wang, J.G. Klijn, Y. Zhang, A.M. Sieuwerts, M.P. Look, F. Yang, D. Talantov, M. Timmermans, M.E. Meijer-van Gelder, J. Yu, T. Jatkoe, E.M. Berns, D. Atkins, J.A. Foekens Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 2005 671 679
17. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J.F. Quackenbush, I.J. Stijleman, J. Palazzo, J.S. Marron, A.B. Nobel, E. Mardis, T.O. Nielsen, M.J. Ellis, C.M. Perou, P.S. Bernard Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167
18. M. Lacroix, G. Leclercq Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res Treat 83 2004 249 289
19. A. Weisz, R. Rosales Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor Nucleic Acids Res 18 1990 5097 5106
20. A.M. Brown, J.M. Jeltsch, M. Roberts, P. Chambon Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7 Proc Natl Acad Sci U S A 81 1984 6344 6348
21. M.G. Ghosh, D.A. Thompson, R.J. Weigel PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer Cancer Res 60 2000 6367 6375
22. M.J. van de Vijver, Y.D. He, L.J. van'T Veer, H. Dai, A.A. Hart, D.W. Voskuil, G.J. Schreiber, J.L. Peterse, C. Roberts, M.J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E.T. Rutgers, S.H. Friend, R. Bernards A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
23. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D. Peterson Jr., R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, S.C. Brooks Isolation and characterization of a spontaneously immortalized human breast epithelial cell line MCF-10 Cancer Res 50 1990 6075 6086
24. P.J. Dawson, S.R. Wolman, L. Tait, G.H. Heppner, F.R. Miller MCF10AT: a model for the evolution of cancer from proliferative breast disease Am J Pathol 148 1996 313 319
25. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, T. Speed, P.T. Spellman, S. DeVries, A. Lapuk, N.J. Wang, W.L. Kuo, J.L. Stilwell, D. Pinkel, D.G. Albertson, F.M. Waldman, F. McCormick, R.B. Dickson, M.D. Johnson, M. Lippman, S. Ethier, A. Gazdar, J.W. Gray A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
26. R.B. Clarke, A. Howell, C.S. Potten, E. Anderson Dissociation between steroid receptor expression and cell proliferation in the human breast Cancer Res 57 1997 4987 4991
27. B.S. Shoker, C. Jarvis, R.B. Clarke, E. Anderson, J. Hewlett, M.P. Davies, D.R. Sibson, J.P. Sloane Estrogen receptor-positive proliferating cells in the normal and precancerous breast Am J Pathol 155 1999 1811 1815
28. B.S. Shoker, C. Jarvis, D.R. Sibson, C. Walker, J.P. Sloane Oestrogen receptor expression in the normal and pre-cancerous breast J Pathol 188 1999 237 244
29. E. Enmark, J.A. Gustafsson Oestrogen receptors - an overview J Intern Med 246 1999 133 138
30. P. Webb, P. Nguyen, C. Valentine, G.N. Lopez, G.R. Kwok, E. McInerney, B.S. Katzenellenbogen, E. Enmark, J.A. Gustafsson, S. Nilsson, P.J. Kushner The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions Mol Endocrinol 13 1999 1672 1685
31. C. Lu, Q. Shen, E. DuPre, H. Kim, S. Hilsenbeck, P.H. Brown cFos is critical for MCF-7 breast cancer cell growth Oncogene 24 2005 6516 6524
32. J.M. Rae, M.D. Johnson, J.O. Scheys, K.E. Cordero, J.M. Larios, M.E. Lippman GREB 1 is a critical regulator of hormone dependent breast cancer growth Breast Cancer Res Treat 92 2005 141 149
33. N. Amiry, X. Kong, N. Muniraj, N. Kannan, P.M. Grandison, J. Lin, Y. Yang, C.M. Vouyovitch, S. Borges, J.K. Perry, H.C. Mertani, T. Zhu, D. Liu, P.E. Lobie Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells Endocrinology 150 2009 4473 4483